Breast Cancer Research Foundation Inc
Breast Cancer Research Foundation Inc. shows strong revenue growth and high program spending efficiency.
EIN: 133727250 · New York, NY · NTEE: M20Z · Updated: 2026-03-28
Is Breast Cancer Research Foundation Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Breast Cancer Research Foundation Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Breast Cancer Research Foundation Inc
Breast Cancer Research Foundation Inc (EIN: 133727250) is a nonprofit organization based in New York, NY, classified under NTEE code M20Z. The organization reported total revenue of $195.6M and total assets of $199.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Breast Cancer Research Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Breast Cancer Research Foundation Inc is a major nonprofit that has been operating for 33 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 7.2%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $94.8M |
| Total Expenses | $77.9M |
| Surplus / Deficit | +$16.9M |
| Total Assets | $153.4M |
| Total Liabilities | $66.8M |
| Net Assets | $86.6M |
| Operating Margin | 17.8% |
| Debt-to-Asset Ratio | 43.6% |
| Months of Reserves | 23.6 months |
Financial Health Grade: A
In 2023, Breast Cancer Research Foundation Inc reported a surplus of $16.9M with revenue exceeding expenses, holds 23.6 months of operating reserves (strong position), has a debt-to-asset ratio of 43.6% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Breast Cancer Research Foundation Inc's revenue has grown at a compound annual growth rate (CAGR) of 7.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +12.1% | +11.4% | +18.0% |
| 2022 | +31.0% | +13.8% | +10.4% |
| 2021 | -15.3% | +6.0% | +11.9% |
| 2020 | -4.2% | -29.5% | -4.3% |
| 2019 | +0.7% | +6.9% | +5.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1993 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Breast Cancer Research Foundation Inc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Breast Cancer Research Foundation Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $16.9M, with revenue exceeding expenses.
- Debt-to-asset ratio: 43.6%.
Executive Compensation Analysis
The provided IRS 990 data consistently reports 0% for Officer Compensation across all listed periods, which is unusual for an organization of this size and revenue. This suggests that executive compensation may be reported under different categories or that key officers are not compensated directly through the organization's payroll in a manner captured by this specific metric.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Breast Cancer Research Foundation Inc's IRS 990 filings:
- Unclear executive compensation reporting (0% officer comp for a large organization)
Strengths
The following positive indicators were identified for Breast Cancer Research Foundation Inc:
- Strong and consistent revenue growth over the past decade
- Significant increase in assets, indicating financial stability and capacity
- High estimated program spending ratio (85%), demonstrating efficient use of funds for mission
- Positive net income in most recent periods (Revenue significantly exceeding Expenses)
Frequently Asked Questions about Breast Cancer Research Foundation Inc
Is Breast Cancer Research Foundation Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Breast Cancer Research Foundation Inc (EIN: 133727250) some concerns. Mission Score: 92/100. 1 red flag identified, 4 strengths noted.
How does Breast Cancer Research Foundation Inc spend its money?
Breast Cancer Research Foundation Inc directs 85% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Breast Cancer Research Foundation Inc tax-deductible?
Breast Cancer Research Foundation Inc is registered as a tax-exempt nonprofit (EIN: 133727250). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Is Breast Cancer Research Foundation Inc. a good charity?
Based on the provided financial data, the Breast Cancer Research Foundation Inc. appears to be a very good charity. It demonstrates strong financial health, significant revenue growth, and a high percentage of spending directed towards its program services (estimated 85%).
How has the organization's revenue changed over time?
The organization has experienced substantial revenue growth, increasing from $58,517,517 in 2014 to $195,619,100 in its latest reported period, with a notable jump from $94,756,928 in 2023.
What is the trend in the organization's assets?
The organization's assets have shown consistent growth, increasing from $91,224,498 in 2014 to $199,068,927 in the latest period, indicating strong financial accumulation and stability.
What is the significance of 'Officer Comp=0%'?
The consistent reporting of 'Officer Comp=0%' across all filings is unusual for an organization of this scale. It could mean that executive compensation is reported under different expense categories, or that key officers are not directly compensated by the organization in a way that is captured by this specific line item on the 990 summary.
Filing History
IRS 990 filing history for Breast Cancer Research Foundation Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Breast Cancer Research Foundation Inc's revenue has grown by 130%, moving from $41.2M to $94.8M. Total assets increased by 207.5% over the same period, from $49.9M to $153.4M. Total functional expenses rose by 89%, from $41.2M to $77.9M. In its most recent filing year (2023), Breast Cancer Research Foundation Inc reported a surplus of $16.9M, with revenue exceeding expenses. The organization holds $66.8M in liabilities against $153.4M in assets (debt-to-asset ratio: 43.6%), resulting in net assets of $86.6M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $94.8M | $77.9M | $153.4M | $66.8M | — | View 990 |
| 2022 | $84.5M | $69.9M | $129.9M | $65.7M | — | View 990 |
| 2021 | $64.5M | $61.4M | $117.8M | $61.5M | — | View 990 |
| 2020 | $76.2M | $57.9M | $105.2M | $60.1M | — | View 990 |
| 2019 | $79.6M | $82.2M | $109.9M | $83.4M | — | View 990 |
| 2018 | $79.0M | $76.9M | $104.4M | $77.1M | — | View 990 |
| 2017 | $73.0M | $71.8M | $91.0M | $68.3M | — | View 990 |
| 2016 | $67.7M | $68.1M | $91.7M | $70.0M | — | View 990 |
| 2015 | $60.1M | $63.1M | $87.9M | $64.2M | — | View 990 |
| 2014 | $58.5M | $66.4M | $91.2M | $62.7M | — | View 990 |
| 2013 | $71.8M | $56.8M | $86.7M | $50.5M | — | View 990 |
| 2012 | $53.6M | $45.4M | $60.1M | $40.5M | — | View 990 |
| 2011 | $41.2M | $41.2M | $49.9M | $37.3M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $94.8M, expenses of $77.9M, and assets of $153.4M (revenue +12.1% year-over-year).
- 2022: Revenue of $84.5M, expenses of $69.9M, and assets of $129.9M (revenue +31.0% year-over-year).
- 2021: Revenue of $64.5M, expenses of $61.4M, and assets of $117.8M (revenue -15.3% year-over-year).
- 2020: Revenue of $76.2M, expenses of $57.9M, and assets of $105.2M (revenue -4.2% year-over-year).
- 2019: Revenue of $79.6M, expenses of $82.2M, and assets of $109.9M (revenue +0.7% year-over-year).
- 2018: Revenue of $79.0M, expenses of $76.9M, and assets of $104.4M (revenue +8.2% year-over-year).
- 2017: Revenue of $73.0M, expenses of $71.8M, and assets of $91.0M (revenue +7.9% year-over-year).
- 2016: Revenue of $67.7M, expenses of $68.1M, and assets of $91.7M (revenue +12.5% year-over-year).
- 2015: Revenue of $60.1M, expenses of $63.1M, and assets of $87.9M (revenue +2.8% year-over-year).
- 2014: Revenue of $58.5M, expenses of $66.4M, and assets of $91.2M (revenue -18.5% year-over-year).
- 2013: Revenue of $71.8M, expenses of $56.8M, and assets of $86.7M (revenue +34.1% year-over-year).
- 2012: Revenue of $53.6M, expenses of $45.4M, and assets of $60.1M (revenue +30.0% year-over-year).
- 2011: Revenue of $41.2M, expenses of $41.2M, and assets of $49.9M.
Data Sources and Methodology
This transparency report for Breast Cancer Research Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.